阿尔茨海默病临床前阶段主观认知功能下降的现况和研究进展

doi:10.16138/j.1673-6087.2023.06.013

摘要/Abstract

关键词: 主观认知功能下降, 阿尔茨海默病, 影像学, 血液, 脑脊液, 治疗

中图分类号:

R749.16

姚敏怡, 刘勇林. 阿尔茨海默病临床前阶段主观认知功能下降的现况和研究进展[J]. 内科理论与实践, 2023, 18(06): 447-450.

YAO Minyi, LIU Yonglin. Current status and research progress of subjective cognitive decline in Alzheimer’s disease of preclinical stage[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(06): 447-450.

参考文献 47

[1]	Wang J, Wang K, Liu T, et al. Abnormal dynamic functional networks in subjective cognitive decline and Alzheimer’s disease[J]. Front Comput Neurosci, 2022, 16: 885126. doi: 10.3389/fncom.2022.885126 URL
[2]	Atri A. The Alzheimer’s disease clinical spectrum[J]. Med Clin North Am, 2019, 103(2): 263-293. doi: 10.1016/j.mcna.2018.10.009 URL
[3]	Wang X, Huang W, Su L, et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease[J]. Mol Neurodegener, 2020, 15(1):55. doi: 10.1186/s13024-020-00395-3
[4]	Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline[J]. Lancet Neurol, 2020, 19(3): 271-278. doi: S1474-4422(19)30368-0 pmid: 31958406
[5]	Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease[J]. Alzheimers Dement, 2018, 14(4):535-562. doi: 10.1016/j.jalz.2018.02.018 URL
[6]	Mitchell A J, Beaumont H, Ferguson D, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis[J]. Acta Psychiatr Scand, 2014, 130(6): 439-451. doi: 10.1111/acps.2014.130.issue-6 URL
[7]	Slot RER, Sikkes SAM, Berkhof J, et al. Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia[J]. Alzheimers Dement, 2019, 15(3): 465-476. doi: 10.1016/j.jalz.2018.10.003 URL
[8]	Jia F, Li Y, Li M, et al. Subjective cognitive decline, cognitive reserve indicators, and the incidence of dementia[J]. J Am Med Dir Assoc, 2021, 22(7): 1449-1455. doi: 10.1016/j.jamda.2020.08.005 pmid: 32967819
[9]	Oliver MD, Morrison C, Kamal F, et al. Subjective cognitive decline is a better marker for future cognitive decline in females than in males[J]. Alzheimers Res Ther, 2022, 14(1): 197. doi: 10.1186/s13195-022-01138-w pmid: 36581949
[10]	Ribaldi F, Rolandi E, Vaccaro R, et al. The clinical heterogeneity of subjective cognitive decline: a data-driven approach on a population-based sample[J]. Age Ageing, 2022, 51(10): afac209.
[11]	Scheef L, Grothe MJ, Koppara A, et al. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline(SCD)[J]. Neuroimage Clin, 2019, 21:101612. doi: 10.1016/j.nicl.2018.101612 URL
[12]	Zhao W, Wang X, Yin C, et al. Trajectories of the hippocampal subfields atrophy in the Alzheimer’s disease[J]. Front Neuroinform, 2019, 13: 13. doi: 10.3389/fninf.2019.00013 URL
[13]	Chen Y, Wang Y, Song Z, et al. Abnormal white matter changes in Alzheimer’s disease based on diffusion tensor imaging[J]. Ageing Res Rev, 2023, 87: 101911. doi: 10.1016/j.arr.2023.101911 URL
[14]	Wen Q, Mustafi SM, Li J, et al. White matter alterations in early-stage Alzheimer’s disease[J]. Alzheimers Dement (Amst), 2019, 11:576-587.
[15]	Ryu SY, Lim EY, Na S, et al. Hippocampal and entorhinal structures in subjective memory impairment[J]. Int Psychogeriatr, 2017, 29(5): 785-792. doi: 10.1017/S1041610216002349 URL
[16]	Brueggen K, Dyrba M, Cardenas-Blanco A, et al. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging[J]. J Neurol, 2019, 266(10): 2465-2474. doi: 10.1007/s00415-019-09429-3
[17]	Selnes P, Fjell AM, Gjerstad L, et al. White matter imaging changes in subjective and mild cognitive impairment[J]. Alzheimers Dement, 2012, 8(5 Suppl): S112-S121.
[18]	Mohammadian F, Zare Sadeghi A, Noroozian M, et al. Quantitative assessment of resting-state functional connectivity MRI to differentiate amnestic mild cognitive impairment, late-onset Alzheimer’s disease from normal subjects[J]. J Magn Reson Imaging, 2023, 57(6): 1702-1712. doi: 10.1002/jmri.v57.6 URL
[19]	Kucikova L, Goerdten J, Dounavi ME, et al. Resting-state brain connectivity in healthy young and middle-aged adults at risk of progressive Alzheimer’s disease[J]. Neurosci Biobehav Rev, 2021, 129: 142-153. doi: 10.1016/j.neubiorev.2021.07.024 URL
[20]	Greicius MD, Krasnow B, Reiss AL, et al. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis[J]. Proc Natl Acad Sci U S A, 2003, 100(1): 253-258. doi: 10.1073/pnas.0135058100 URL
[21]	Jobson DD, Hase Y, Clarkson AN, et al. The role of the medial prefrontal cortex in cognition, ageing and dementia[J]. Brain Commun, 2021, 3(3): fcab125.
[22]	Spreng RN, Turner GR. The shifting architecture of cognition and brain function in older adulthood[J]. Perspect Psychol Sci, 2019, 14(4): 523-542. doi: 10.1177/1745691619827511 pmid: 31013206
[23]	Sun Y, Dai Z, Li Y, et al. Subjective cognitive decline: mapping functional and structural brain changes-A combined resting-state functional and structural MR imaging study[J]. Radiology, 2016, 281(1): 185-192. doi: 10.1148/radiol.2016151771 pmid: 27002419
[24]	Yang L, Yan Y, Wang Y, et al. Gradual disturbances of the amplitude of low-frequency fluctuations(ALFF) and fractional ALFF in Alzheimer spectrum[J]. Front Neurosci, 2018, 12: 975.
[25]	Viviano RP, Hayes JM, Pruitt PJ, et al. Aberrant memory system connectivity and working memory performance in subjective cognitive decline[J]. Neuroimage, 2019, 185: 556-564. doi: S1053-8119(18)31974-8 pmid: 30308246
[26]	Dillen KNH, Jacobs HIL, Kukolja J, et al. Aberrant functional connectivity differentiates retrosplenial cortex from posterior cingulate cortex in prodromal Alzheimer’s disease[J]. Neurobiol Aging, 2016, 44:114-126. doi: S0197-4580(16)30037-9 pmid: 27318139
[27]	Mak E, Bethlehem RAI, Romero-Garcia R, et al. In vivo coupling of tau pathology and cortical thinning in Alzheimer’s disease[J]. Alzheimers Dement (Amst), 2018, 10: 678-687.
[28]	Ersoezlue E, Rauchmann BS, Schneider-Axmann T, et al. Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer’s disease[J]. Neurobiol Aging, 2023, 122: 33-44. doi: 10.1016/j.neurobiolaging.2022.05.015 URL
[29]	Parker AF, Smart CM, Scarapicchia V, et al. Identification of earlier biomarkers for Alzheimer’s disease: a multimodal neuroimaging study of individuals with subjective cognitive decline[J]. J Alzheimers Dis, 2020, 77(3): 1067-1076. doi: 10.3233/JAD-200299 URL
[30]	Chen H, Sheng X, Luo C, et al. The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline[J]. Transl Neurodegener, 2020, 9(1): 21. doi: 10.1186/s40035-020-00201-6 pmid: 32460888
[31]	Bao YW, Shea YF, Chiu PK, et al. The fractional amplitude of low-frequency fluctuations signals related to amyloid uptake in high-risk populations[J]. Front Aging Neurosci, 2022, 14: 956222. doi: 10.3389/fnagi.2022.956222 URL
[32]	Sharma N, Murari G, Vandermorris S, et al. Functional connectivity between the posterior default mode network and parahippocampal gyrus is disrupted in older adults with subjective cognitive decline and correlates with subjective memory ability[J]. J Alzheimers Dis, 2021, 82(1): 435-445. doi: 10.3233/JAD-201579 pmid: 34024823
[33]	Schwarz C, Benson GS, Antonenko D, et al. Negative affective burden is associated with higher resting-state functional connectivity in subjective cognitive decline[J]. Sci Rep, 2022, 12(1): 6212. doi: 10.1038/s41598-022-10179-y pmid: 35418579
[34]	Dhiman K, Blennow K, Zetterberg H, et al. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis[J]. Cell Mol Life Sci, 2019, 76(10):1833-1863. doi: 10.1007/s00018-019-03040-5 pmid: 30770953
[35]	Wen C, Bi YL, Hu H, et al. Association of subjective cognitive decline with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults[J]. J Alzheimers Dis, 2022, 85(3): 1143-1151. doi: 10.3233/JAD-215178 URL
[36]	Cicognola C, Hansson O, Scheltens P, et al. Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias[J]. Alzheimers Res Ther, 2021, 13(1): 38. doi: 10.1186/s13195-020-00756-6 pmid: 33557920
[37]	Mantzavinos V, Alexiou A. Biomarkers for Alzheimer’s disease diagnosis[J]. Curr Alzheimer Res, 2017, 14(11):1149-1154. doi: 10.2174/1567205014666170203125942 pmid: 28164766
[38]	Zetterberg H, Blennow K. Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics[J]. Mol Neurodegener, 2021, 16(1): 10. doi: 10.1186/s13024-021-00430-x pmid: 33608044
[39]	Prins S, Zhuparris A, Groeneveld GJ. Usefulness of plasma amyloid as a prescreener for the earliest Alzheimer pathological changes depends on the study population[J]. Ann Neurol, 2020, 87(1): 154-155. doi: 10.1002/ana.25634 pmid: 31675127
[40]	Wang X, Zhao M, Lin L, et al. Plasma β-amyloid levels associated with structural integrity based on diffusion tensor imaging in subjective cognitive decline[J]. Front Aging Neurosci, 2021, 12: 592024. doi: 10.3389/fnagi.2020.592024 URL
[41]	Müller S, Preische O, GÖpfert JC, et al. Tau plasma levels in subjective cognitive decline: results from the DELCODE study[J]. Sci Rep, 2017, 7(1): 9529. doi: 10.1038/s41598-017-08779-0 pmid: 28842559
[42]	Verberk IMW, Thijssen E, Koelewijn J, et al. Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology[J]. Alzheimers Res Ther, 2020, 12(1): 118. doi: 10.1186/s13195-020-00682-7 pmid: 32988409
[43]	Rusek M, Pluta R, Ułamek-Kozioł M, et al. Ketogenic diet in Alzheimer’s disease[J]. Int J Mol Sci, 2019, 20(16):3892. doi: 10.3390/ijms20163892 URL
[44]	Tao Y, Leng SX, Zhang H. Ketogenic diet: an effective treatment approach for neurodegenerative diseases[J]. Curr Neuropharmacol, 2022, 20(12): 2303-2319. doi: 10.2174/1570159X20666220830102628 pmid: 36043794
[45]	Danial NN, Hartman AL, Stafstrom CE, et al. How does the ketogenic diet work?[J]. J Child Neurol, 2013, 28(8): 1027-1033. doi: 10.1177/0883073813487598 pmid: 23670253
[46]	Neth BJ, Mintz A, Whitlow C, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease[J]. Neurobiol Aging, 2020, 86: 54-63. doi: 10.1016/j.neurobiolaging.2019.09.015 URL
[47]	Chong TWH, Curran E, Ellis KA, et al. Physical activity for older Australians with mild cognitive impairment or subjective cognitive decline[J]. J Sci Med Sport, 2020, 23(10): 913-920. doi: 10.1016/j.jsams.2020.03.003 URL

阿尔茨海默病临床前阶段主观认知功能下降的现况和研究进展

Current status and research progress of subjective cognitive decline in Alzheimer’s disease of preclinical stage

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 47

相关文章 15

编辑推荐

Metrics

本文评价

[1]	范存秀, 乐卫东, 王晓平. 第17届世界神经病学争议大会纪要[J]. 内科理论与实践, 2023, 18(06): 457-460.
[2]	王创琦, 王茜, 王文威, 吴霏霏, 章艳琳. 精细化水化方案对预防异基因造血干细胞移植后并发出血性膀胱炎的研究[J]. 内科理论与实践, 2023, 18(06): 431-435.
[3]	黄容, 刘警安, 朱奕霖, 施小凤. microRNA在急性白血病中的作用及研究进展[J]. 内科理论与实践, 2023, 18(06): 451-456.
[4]	徐丽辰, 李贵森. 局灶节段性肾小球硬化发病机制及治疗进展[J]. 内科理论与实践, 2023, 18(05): 363-367.
[5]	韦敏, 李元媛, 赵月婷, 徐书杭, 丁文波, 陈国芳, 刘超. 1例急性化脓性甲状腺炎并发食管瘘[J]. 内科理论与实践, 2023, 18(05): 352-355.
[6]	白娅娅, 唐碧雯, 胡月亮, 左君丽, 姚玮艳. 71例嗜酸细胞性胃肠炎的临床特征和预后分析[J]. 内科理论与实践, 2023, 18(04): 270-277.
[7]	张会健, 李贵森. IgA肾病补体靶向治疗研究进展[J]. 内科理论与实践, 2023, 18(03): 197-200.
[8]	赖莉琴, 龚艳春. 原发性醛固酮增多症慢性肾损伤的研究进展[J]. 内科理论与实践, 2023, 18(03): 211-214.
[9]	徐凯, 李百文. 早期胃癌及胃癌前病变的内镜黏膜下剥离术治疗[J]. 内科理论与实践, 2023, 18(02): 102-106.
[10]	戴生明, 鲍春德, 邹和建, 杨程德, 何东仪, 姜林娣, 管剑龙, 叶霜, 陈盛, 薛愉, 吴歆, 顾晓丽, 李跃华, 徐沪济. 应用磁共振成像诊断和评估骶髂关节炎的专家共识[J]. 内科理论与实践, 2023, 18(02): 65-69.
[11]	瞿介明, 时国朝, 李庆云, 周敏, 程齐俭, 陈巍, 冯耘, 周剑平. 瑞金医院新型冠状病毒肺炎诊治简明方案（2023年1月版）[J]. 内科理论与实践, 2023, 18(01): 1-4.
[12]	中华医学会内分泌学分会. 骨质疏松症新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 22-24.
[13]	欧阳彦, 陈孜瑾, 章倩莹, 陈晓农, 谢静远, 任红, 张文, 王伟铭. 慢性肾脏病人群的新型冠状病毒感染临床诊治建议（瑞金医院2023版）[J]. 内科理论与实践, 2023, 18(01): 28-33.
[14]	吴晓静, 王伟铭. 血液透析患者合并新型冠状病毒感染瑞金医院诊治建议（2023版）[J]. 内科理论与实践, 2023, 18(01): 34-35.
[15]	任佳逸, 糜坚青. 新型抗体类药物在急性B淋巴细胞白血病中的治疗进展[J]. 内科理论与实践, 2022, 17(06): 463-467.